Vista Pharma.

{
  "main_header": {
    "sid": 384463,
    "name": "Vista Pharma.",
    "stock_name": "Vista Pharma.",
    "full_name": "Vista Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/vista-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5.88",
    "chg": 0.27,
    "chgp": "4.81%",
    "dir": 1,
    "prev_price": "5.61",
    "mcapval": "36.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524711,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE427C01021",
    "curr_date": "Sep 18, 03:30 PM",
    "curr_time": "09:36 AM",
    "last_traded_at": "Sep 18, 03:30 PM IST",
    "bse_nse_vol": "15.32 k",
    "exc_status": "Active",
    "traded_date": "Sep 18, 2026",
    "traded_date_str": "2026 09 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vista-pharma-384463-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vista Pharmaceuticals Ltd Falls to 52-Week Low of Rs 5.41 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-ltd-stock-hits-52-week-low-amidst-continued-downtrend-4194700",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VistaPharmaceut_priceRelatedfactors_4194700.png",
        "date": "2026-09-16 09:41:04",
        "description": ""
      },
      {
        "title": "Vista Pharmaceuticals Ltd Falls to 52-Week Low of Rs 5.5 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-ltd-stock-falls-to-52-week-low-of-rs55-4186820",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VistaPharmaceut_priceRelatedfactors_4186820.png",
        "date": "2026-09-08 14:45:14",
        "description": "For the second consecutive session, Vista Pharmaceuticals Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 5.5 on 8 Sep 2026. This latest drop extends the stock’s downward trajectory, which has now resulted in a 5.41% loss over just two days, underscoring persistent selling pressure amid broader market weakness."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4171508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/VistaPharmaceut_mojoScore_4171508.png",
        "date": "2026-08-27 10:10:22",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024. However, the analysis and financial metrics discussed below reflect the company’s current position as of 27 August 2026, providing investors with the latest insights into the stock’s performance and outlook."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4150077",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/VistaPharmaceut_mojoScore_4150077.png",
        "date": "2026-08-12 10:11:22",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024, but the analysis below reflects the stock’s current position as of 12 August 2026, incorporating the latest fundamentals, returns, and financial metrics available today."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4125762",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VistaPharmaceut_mojoScore_4125762.png",
        "date": "2026-07-29 10:10:57",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Jul 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 July 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4103704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VistaPharmaceut_mojoScore_4103704.png",
        "date": "2026-07-15 10:10:33",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 July 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4081545",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VistaPharmaceut_mojoScore_4081545.png",
        "date": "2026-07-01 10:10:22",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 01 July 2026, providing investors with the latest insights into its performance and prospects."
      }
    ],
    "total": 5729,
    "sid": "384463",
    "stock_news_url": "https://www.marketsmojo.com/news/vista-pharmaceuticals-384463"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "12-Sep-2026",
      "details": "Resignation of Company Secretary & Compliance Officer",
      "source": "BSE"
    },
    {
      "caption": "Results For The Quarter Ended 30.06.2026",
      "datetime": "14-Aug-2026",
      "details": "Results for the quarter ended 30.06.2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Results For The Quarter Ended 30.06.2026",
      "datetime": "14-Aug-2026",
      "details": "Results for the quarter ended 30.06.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vista Pharmaceuticals Ltd Falls to 52-Week Low of Rs 5.41 as Sell-Off Deepens

2026-09-16 09:41:04

Read full news article

Vista Pharmaceuticals Ltd Falls to 52-Week Low of Rs 5.5 as Sell-Off Deepens

2026-09-08 14:45:14

For the second consecutive session, Vista Pharmaceuticals Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 5.5 on 8 Sep 2026. This latest drop extends the stock’s downward trajectory, which has now resulted in a 5.41% loss over just two days, underscoring persistent selling pressure amid broader market weakness.

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-08-27 10:10:22

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024. However, the analysis and financial metrics discussed below reflect the company’s current position as of 27 August 2026, providing investors with the latest insights into the stock’s performance and outlook.

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-08-12 10:11:22

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024, but the analysis below reflects the stock’s current position as of 12 August 2026, incorporating the latest fundamentals, returns, and financial metrics available today.

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-07-29 10:10:57

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Jul 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-07-15 10:10:33

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 July 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-07-01 10:10:22

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 01 July 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

View All News